-
Novartis Suspends Production of Two Radioligand Drugs Due to Potential Quality Issues
Novartis announced on Thursday that it has suspended production of neuroendocrine tumor treatment Lutathera and recently FDA-approved prostate cancer ...
2022-05-07 14:58 -
Three Months Extension! FDA Delays Pfizer's Myfembree Supplemental New Drug Application
Just a month ago, the US FDA expressed concern about the supplemental new drug application for the drug Myfembree (relugolix) jointly developed by Pfi...
2022-05-07 14:51 -
FDA Withdraws Accelerated Approval for Bristol-Myers Squibb's PTCL Indication for Romidepsin
On May 6, the U.S. FDA officially announced that it had withdrawn the approval of Bristol-Myers Squibb’s Istodax (romidepsin, romidepsin) for periphe...
2022-05-07 14:49 -
The Global Pharmaceutical Innovation Index is released!
A few days ago, IDEA Pharma, a British pharmaceutical consulting company, released the 2022 Pharmaceutical Innovation Index and Pharmaceutical Inventi...
2022-05-07 11:50 -
API: Industrial Upgrading, Industrial Extension
As always, the 14th Five-Year Plan emphasises the green development of the API industry, pointing out that as the pharmaceutical industry moves toward...
2022-05-06 18:12 -
Global Pharmaceutical Innovation: Adhere to Open Development, Win-win Cooperation
The "14th Five-Year Plan" emphasizes the adherence to open development, win-win cooperation, and an active response to global pharmaceutical innovatio...
2022-05-06 16:46 -
Clinical Usage and Compatibility of Doxycycline Hydrochloride
Doxycycline hydrochloride, also known as doxycycline hydrochloride and deoxyoxytetracycline, is a tetracycline antibiotic with broad-spectrum antibact...
2022-05-06 11:18 -
Accelerate Technological Breakthroughs in Product Innovation and Promote the Industrialization and A...
Promote enterprises to focus on unmet clinical needs and increase investment in the development of innovative products.
2022-05-05 17:22 -
Open Cooperation and Accelerate International Development
The internationalisation targets of the 13th Five-Year Plan set for 2016 are: stable growth in pharmaceutical exports, with the value of exports deliv...
2022-05-05 16:56 -
China's Pharmaceutical Industry Adheres to Innovation Leadership, And Innovation-driven Transformati...
The target for R&D investment in the 13th Five-Year Plan formulated in 2016 is: by 2020, the R&D investment intensity of enterprises above the scale o...
2022-05-05 15:27
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- Sally Beauty Acquires Flair Ha... Jul 07, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
Related Products
Related Producers
